Read more

Apple’s Aura of Invincibility Takes a Hit After Patent Settlement with Marathon and RPI

Apple Inc.’s (APPL) aura of invincibility took a hit this week when it agreed to pay $24.5 million to settle an enforcement action filed by Marathon Patent Group (MARA) and Rensselaer Polytechnic Institute over patents related to the Siri personal assistant application. The company’s willingness to settle reveals a truism that is often underappreciated today […]

Read more

Investors Pursuing Trading Strategy Around Biologics Patent Disputes

Patent investors looking for risk uncorrelated to the equity markets may want to consider a new trading strategy focused on disputes over biologic and biosimilar patents developed by the partners of a high-end boutique IP law firm, its investment consulting affiliate and an affiliated hedge fund. Gaston Kroub, Zachary Silbersher and Sergey Kolmykov are former […]

Read more

PatentVue is New Name of the Envision IP Blog

Envision IP, a boutique law firm focused on patent research that enables better business decisions, has changed the name of its blog from the Envision IP blog to PatentVue. PatentVue will provide the same timely stories that focus on original patent research related to technology deals and product innovations. Recent posts has included: “Alcatel-Lucent Patents […]

Read more

Under Armour May Consider Strategic Patent Acquisitions in the Future

Under Armour Incorporated announced yesterday its acquisition of mobile fitness applications Myfitnesspal and Endomondo.   These acquisitions follow Under Armour’s purchase of MapMyFitness in 2013. With the increasing popularity of wearable devices and mobile fitness and nutrition-related applications, it appears that Under Armour will be expanding its offerings in this space.

Read more

SCOTUS: Higher Bar Required for Broad Patents in Nautilus v. Biosig

In a decision likely to have a significant impact on the validity of broad patents, the United States Supreme Court reversed a Federal Circuit decision in Nautilus Inc. v. Biosig Instruments Inc. today. The issues at hand in the case were (1) whether the Federal Circuit’s acceptance of ambiguous patent claims with multiple reasonable interpretations – so long […]